Loading…
CD4 + and CD8 + regulatory T cell characterization in the rat using a unique transgenic Foxp3-EGFP model
Regulatory T cells (Treg) in diverse species include CD4 and CD8 T cells. In all species, CD8 Treg have been only partially characterized and there is no rat model in which CD4 and CD8 FOXP3 Treg are genetically tagged. We generated a Foxp3-EGFP rat transgenic line in which FOXP3 gene was expressed...
Saved in:
Published in: | BMC biology 2023-01, Vol.21 (1), p.8-8, Article 8 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Regulatory T cells (Treg) in diverse species include CD4
and CD8
T cells. In all species, CD8
Treg have been only partially characterized and there is no rat model in which CD4
and CD8
FOXP3
Treg are genetically tagged.
We generated a Foxp3-EGFP rat transgenic line in which FOXP3 gene was expressed and controlled EGFP. CD4
and CD8
T cells were the only cells that expressed EGFP, in similar proportion as observed with anti-FOXP3 antibodies and co-labeled in the same cells. CD4
EGFP
Treg were 5-10 times more frequent than CD8
EGFP
Treg. The suppressive activity of CD4
and CD8
Treg was largely confined to EGFP
cells. RNAseq analyses showed similarities but also differences among CD4
and CD8
EGFP
cells and provided the first description of the natural FOXP3
CD8
Treg transcriptome. In vitro culture of CD4
and CD8
EGFP
cells with TGFbeta and IL-2 generated induced EGFP
Treg. CD4
and CD8
EGFP
Treg were expanded upon in vivo administration of a low dose of IL-2.
This new and unique rat line constitutes a useful model to identify and isolate viable CD4
and CD8
FOXP3
Treg. Additionally, it allows to identify molecules expressed in CD8
Treg that may allow to better define their phenotype and function not only in rats but also in other species. |
---|---|
ISSN: | 1741-7007 1741-7007 |
DOI: | 10.1186/s12915-022-01502-0 |